Ascitic Microbiota Composition Is Correlated with Clinical Severity in Cirrhosis with Portal Hypertension by Rogers, GB et al.
Ascitic Microbiota Composition Is Correlated with Clinical
Severity in Cirrhosis with Portal Hypertension
Geraint B. Rogers1*, Christopher J. van der Gast2, Kenneth D. Bruce1, Peter Marsh3, Jane E. Collins4,
Julian Sutton3, Mark Wright4
1 Institute of Pharmaceutical Science, King’s College London, London, United Kingdom, 2NERC Centre for Ecology and Hydrology, Wallingford, United Kingdom, 3Health
Protection Agency, Southampton General Hospital, Southampton, United Kingdom, 4Hepatology Group, Southampton General Hospital, Southampton, United Kingdom
Abstract
Identification of pathogenic bacteria in ascites correlates with poor clinical outcomes. Ascites samples are commonly
reported culture-negative, even where frank infection is indicated. Culture-independent methods have previously reported
bacterial DNA in ascites, however, whether this represents viable bacterial populations has not been determined. We report
the first application of 16S rRNA gene pyrosequencing and quantitative PCR in conjunction with propidium monoazide
sample treatment to characterise the viable bacterial composition of ascites. Twenty five cirrhotic patients undergoing
paracentesis provided ascites. Samples were treated with propidium monoazide to exclude non-viable bacterial DNA. Total
bacterial load was quantified by 16S rRNA Q-PCR with species identity and relative abundance determined by 16S rRNA
gene pyrosequencing. Correlation of molecular microbiology data with clinical measures and diagnostic microbiology was
performed. Viable bacterial signal was obtained in 84% of ascites samples, both by Q-PCR and pyrosequencing.
Approximately 190,000 ribosomal pyrosequences were obtained, representing 236 species, including both gut and non gut-
associated species. Substantial variation in the species detected was observed between patients. Statistically significant
relationships were identified between the bacterial community similarity and clinical measures, including ascitic
polymorphonuclear leukocyte count and Child-Pugh class. Viable bacteria are present in the ascites of a majority of
patients with cirrhosis including those with no clinical signs of infection. Microbiota composition significantly correlates
with clinical measures. Entry of bacteria into ascites is unlikely to be limited to translocation from the gut, raising
fundamental questions about the processes that underlie the development of spontaneous bacterial peritonitis.
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Introduction
Bacterial infection is increasingly recognised to be a key driver
in the development of complications in end stage liver disease.
Spontaneous bacterial peritonitis (SBP) has been thought to result
from translocation of gut bacteria into previously sterile ascites.
Such infections have range of adverse outcomes, including hepatic
encephalopathy and changes in portal pressure [1]. SBP occurs in
up to 25% of patients with cirrhosis and ascites [2] with an in-
hospital mortality rate ranging from 20 to 40% [3].
However, even where thorough microbiological practice is
employed, ascitic fluid culture is reported as negative in ,20–60%
of patients with clinical manifestations suggestive of SBP, including
elevated ascites polymorphonuclear leukocyte (PMN) counts
($250 cells/mm3) [4,5]. Further, patients with a PMN count
$250 cells/mm3 with culture-negative ascites have similar signs,
symptoms and mortality rates as patients whose ascites is culture
positive [6]. This failure to routinely identify an infective agent
means that empirical antibiotic treatment for SBP is initiated when
objective evidence of a local inflammatory reaction is present,
commonly without knowledge of the causative organisms or their
antibiotic susceptibility [6], with success inferred from improve-
ments in clinical measures, rather than through the direct
observation of an impact on the pathogen. The absence of a
detailed understanding of the bacteria that are present in ascites,
and their role in the development of SBP, and whether a
preclinical, bactero-ascitic phase is likely to precede SBP might
exist, greatly hampers the development of more effective treatment
regimens.
The limitations of culture-based diagnostics are increasingly
well recognised [7,8] with failure to identify a causative agent
where infection is apparent being shown to occur in many clinical
scenarios [9]. Such discrepancies have led to an increased
deployment of culture-independent, molecular techniques, based
on the detection of nucleic acid sequence signatures. The
application of nucleic acid based assays to the analysis of ascites
has shown that merely detecting the presence of bacterial DNA
can be clinically informative, acting as a surrogate marker of
bacterial translocation [10]. Further, after certain exclusions, the
presence of bacterial DNA has been shown to independently
predict 12-month mortality in patients with culture-negative, non-
neutrocytic ascites [11].
In addition to the detection of bacterial signal, DNA-based
approaches can also be used to both quantify and identify the
bacterial species present. Here, approaches typically exploit the
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phylogenetically informative 16S ribosomal RNA gene, and
include quantitative (Q) PCR (a means of determining bacterial
load) and pyrosequencing (a massive parallel sequencing approach
that allows the rapid, high depth characterisation of bacterial
composition). Such approaches have been applied across a wide
range of clinical contexts, including the analysis of intestinal
microbial communities of cirrhotic patients [12], and the
identification of bacterial species present in ascites [13] (although
the presented study is the first reported use of pyrosequencing in
this context). However, whilst having the potential to be greatly
informative, such molecular techniques are weakened by their
inability to distinguish between DNA present in viable bacterial
cells, from that present in dead bacteria or in the extracellular
environment. When applied to a clinical context, particularly
where antimicrobials are being deployed, this inability is critical. A
solution to this problem is to treat samples with propidium
monoazide (PMA) prior to the extraction of DNA, a process that
prevents the contribution of DNA other than that present in viable
bacterial from contributing to subsequent PCR-based analysis.
Such an approach has been shown to be effective in a range of
contexts [14–23].
The aim of this study was to apply a molecular approach to the
characterisation of the bacterial content of ascites that both
excludes non-viable cells and allows the detection of bacteria that
are refractory to culture in vitro. We hypothesised that: 1)
suppression of signal derived from naked DNA or DNA present
in non-viable bacteria would result in a reduction in bacterial
signal compared to previous culture independent studies; 2) despite
this reduction, viable bacterial cells would be detectable in a
significant proportion of ascites, including those reported to be
culture negative; 3) characteristics of the ascitic bacterial
community composition determined in this way would be related
to clinical measures of disease.
Here we present the first application of culture-independent
techniques in conjunction with PMA sample treatment to
characterise the bacterial composition of ascites. A combination
of 16S rRNA gene pyrosequencing and 16S rRNA gene Q-PCR
to identify and quantify the bacteria present, with the resulting
data correlated with clinical measures of disease.
Materials and Methods
Clinical Samples
Ascites samples were obtained from 25 consecutive cirrhotic
patients undergoing clinically indicated therapeutic or diagnostic
paracentesis for ascites at Southampton General Hospital,
Hampshire, UK, under full ethical approval (08/H0502/119
National Research Ethics Service Southampton & South West
Hampshire Research Ethics Committee A) (Table 1). All
participants provided written informed consent, using a consent
procedure approved by the ethics committee.
Child Pugh Score was determined by an experienced hepatol-
ogist (MW). Bloods were drawn on the day of the procedure.
Ascites was drawn under aseptic conditions from the flank. PMN
estimation and culture-based microbiology were performed as part
of standard clinical practice [6]. Approximately 20 ml of ascitic
fluid from each patient was centrifuged at 6,0006g for 10 min,
with the resulting cell pellets resuspended in 0.5 ml of sterile
phosphate-buffered saline (PBS) and stored at 280uC prior to
culture-independent analysis.
Sample Processing
Resuspended cell pellets were treated with PMA based on the
method described previously [19]. Negative control samples,
comprised of DNA-free water that had been used to rinse empty
ascites collection vessels, were processed in parallel to clinical
samples. Briefly, PMA was dissolved in 20% dimethyl sulfoxide to
create a stock concentration of 20 mmol/L, 1.25 mL of which was
added to 500 mL of resuspended cells. Cells were incubated for
15 min at room temperature, with occasional shaking, followed by
the addition of a further 1.25 mL of PMA solution, and a further
15 min incubation. Following incubation, pellets were exposed to
light for 10 min using an LED Active Blue equipment light source
(Ingenia Biosystems, Terrassa, Spain). Total DNA extraction was
then performed as described previously [13]. Full details of the
protocol used are provided as Methods S1.
Quantitative PCR
Total bacterial density was determined using a Taqman assay,
in which a 466 bp fragment of the 16S ribosomal RNA gene was
amplified. This assay was described previously [24], and applied in
the analysis of ascites [13]. Full details of the protocol used are
provided as Methods S1.
16S rRNA Gene Pyrosequencing
Bacterial tag-encoded FLX amplicon pyrosequencing (bTEFAP)
was performed as described previously [22]. A full description of the
methodology is provided as Methods S1.
Statistical Analysis
Full details of statistical analysis are provided as Methods S1. A
number of statistical tools used in the analysis of microbial
communities to assess measures of diversity and relative abun-
dance, as well as to assess similarity between communities in
different samples, were employed here. In brief, species richness
(S*) was estimated as previously described [25]. Differences in S*
were computed using a re-sampling randomization method, as
previously described [26]. The Sørensen presence/absence and
Bray-Curtis quantitative indices of similarity and subsequent
average linkage clustering of community profiles were performed
using the PAST (version 2.16). Similarity of Percentages (SIM-
PER) analysis, used to determine the contribution of each species
to the observed similarity between samples (Bray-Curtis measure),
was performed as described previously [27]. Mantel tests were
performed as previously described [28].
Results
All clinical samples included in this study were reported as
negative for bacterial growth based on standard diagnostic
microbiological analysis. Patients 1 and 3 had previously provided
samples that had reported ‘‘Gram positive cocci’’.
Prior to DNA extraction, all samples were PMA treated to limit
the contribution of DNA from sources other than viable bacterial
cells. No bacterial signal was subsequently detected in any of the
negative controls. In addition, whilst PMA treatment has been
validated previously as a means of limiting amplification to live cell
extracted DNA, it was further demonstrated to prevent the
amplification of both Gram positive and Gram negative bacterial
strains pelleted from suspension in portions of sterile ascitic fluid
(Figure S1).
16S rRNA Q-PCR resulted in amplification in 21 of the 25
samples, with no amplification recorded for samples from patients
5, 13, 18 and 19. Viable bacterial densities for the 21 samples
where amplification was achieved ranged from to 1.56103 to
7.26105 cfu/ml equiv., with a mean bacterial density of
1.56105 cfu/ml equiv (std dev 1.86105, n= 21). No significant
relationship was observed between viable bacterial load and
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clinical measures, including ascitic fluid white cell count, blood
total white cell count, blood neutrophil count, serum creatinine,
survival, and time until other clinical events (SBP, as measured by
the occurrence of an ascitic fluid PMN .250 cells/mm3; and
acute gastrointestinal bleeding requiring transfusion) (Pearson’s
correlation, P.0.05 in all instances).
DNA extracts for all 25 samples were next subjected to 16S
rRNA gene pyrosequencing. In keeping with the results of Q-PCR
analysis, PCR amplification, and subsequent pyrosequencing,
were successful for 21 of the 25 samples. A total of 189,960 16S
rRNA sequences were obtained, with an average of 9045
sequences per sample (SD 68642, n=21, range 1901–39522).
Members of the phyla Proteobacteria dominated the sequences
obtained (53.9%), followed by Firmicutes (21.2%), Actinobacteria
(17.4%), and Bacteroidetes (4.4%), with other phyla representing
3.1% of sequences (Figure 1). In total, 236 unique bacterial species
were detected across the 21 samples analysed. Species identities,
occupancy (the number of samples a given species was detected in)
and anaerobicity are shown in Table S1.
Bacterial species richness (number of species) was calculated
based on uniform re-sample of 16S rRNA gene sequences, and
ranged from 10 to 69 species per sample with a mean richness of
26.7 (SD 613.0, n = 21) (Figure 2). To investigate whether the
frequent detection of bacterial species within the patient group
(expressed as occupancy) was positively correlated to their relative
abundance within the samples, the distribution of bacterial species
across the patient group was determined. Here, occupancy was
found to not have a significant relationship with mean species
abundance (r2 = 0.084, F1,234 = 1.38, P=0.242) (Figure 3). Further,
a high number of taxa that were detected with high relative
abundances were unique to a given individual patients.
Similarities and differences in bacterial community membership
and structure between patient samples were assessed using the
Sørensen (based on the presence/absence of species) and Bray-
Curtis (based on presence/absence of species and their relative
abundance) indices of similarity, respectively (Figure 2). The mean
similarity of bacterial communities taken pairwise using the
Sørensen index was 0.31 with a standard deviation of 60.14
(n = 210 pairwise comparisons). For the Bray-Curtis index, the
mean similarity was 0.1460.13 (Figure 2). Clustering of patient
community profiles using both measures are shown as cluster
diagrams in Figure S2. Both box plots and cluster analyses
revealed low levels of similarity in terms of community member-
ship and structure between patients.
SIMPER analysis of bacterial community similarity (Bray-
Curtis index) between patients was performed to determine the
average contribution of a given species to the average similarity
between the samples analysed. Whilst overall levels of similarity
between the bacterial profiles from different patients were low,
species that contributed most to the similarity observed are listed
in Table 2. Here, species occupancy, the mean percentage
abundance of species across the samples in which a species was
detected, the percentage contribution (mean contribution divided
by mean similarity across samples) and percentage cumulative
contribution, are shown in for the five species with the highest
percentage contribution to overall similarity (Acidovorax facilis,
Stenotrophomonas maltophilia, Propionibacterium acnes, Streptococcus pneu-
moniae, and Ralstonia pickettii).
Correlation of bacterial community similarity (measured using
Sørensen or Bray-Curtis indices of similarity) with a number of
clinical measures (antibiotic therapy, Child-Pugh Score, and PMN
count) was performed using Mantel tests. The Mantel statistic (r)
and the significance of differences between Mantel regression
coefficients and zero following 9,999 permutations, P, are shown
in Table 3. Statistically-significant relationships were identified
between Bray-Curtis similarity indices and ascitic PMN
(P,0.0001), SBP diagnosis (P= 0.002), Child-Pugh class
(P= 0.011), When Sørensen similarity indices were used, a
Figure 1. Phyla represented by 16S rRNA gene sequences
obtained.
doi:10.1371/journal.pone.0074884.g001
Figure 2. Box plot comparisons of bacterial diversity, bacterial
community membership, and bacterial community structure
for the 21 cross-sectional samples (A, B, and C, respectively).
Richness was calculated with a uniform re-sample size of 1901
sequences following 1000 iterations. Community membership and
structure were calculated using the Sørensen (presence/absence) and
Bray-Curtis (quantitative) indices of similarity, respectively. The top and
bottom boundaries of each box plot indicate the 75th and 25th quartile
values, respectively, and lines within each box represent the 50th
quartile (media) values. Ends of whiskers represent interquartile range
and open circles mark the lowest and highest values in each instance.
doi:10.1371/journal.pone.0074884.g002
Figure 3. Distribution of bacterial species across patients. Given
is occupancy, (the number of samples for which each bacterial species
was observed), plotted against mean species abundance (log10 scale)
across all 21 samples (r2 = 0.084, F1,234 = 1.38, P= 0.242).
doi:10.1371/journal.pone.0074884.g003
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significant relationship was identified with Child-Pugh class
(P= 0.003). Partial Mantel tests indicated significant relationships
between Bray-Curtis similarity indices and both ascitic PMN
(P,0.0001) and Child-Pugh class (P= 0.003) when one of these
two factors was controlled for. No correlation was observed
between bacterial community similarity and whether subjects had
alcoholic liver disease. In summary, the ascitic microbiology is
similar amongst patients with less severe disease, as is the ascitic
microbiology amongst patients with more severe disease.
Discussion
This is the first culture independent survey of the ascitic
microbiota using the 16S rRNA gene pyrosequencing. Distinct
viable bacterial community profiles were found in the majority of
the patients studied. Differences in structure and membership of
these communities correlated with disease severity and ascitic
PMN.
High rates of culture negativity in the diagnostic microbiological
analysis of ascites samples, even where there are clinical signs of
infection, suggest that such methods are poor in characterising the
bacteria present. Further support for this was provided by previous
culture-independent analysis of ascites samples which reported the
presence of DNA derived from a diverse array of bacterial species
[13]. However, in the absence of a strong correlation between the
presence of bacterial DNA and the occurrence of SBP, we
hypothesised that naked DNA present in ascitic fluid, or DNA
present in non-viable bacteria, may contribute significantly to such
PCR-based signals, potentially obscuring any relationship between
microbes and clinical parameters. To limit culture-independent
analysis to viable bacterial cells, PMA sample treatment was
employed. Prior to its application to ascites samples, we first
confirmed the efficacy of this approach by spiking sterile ascitic
fluid with heat-killed Gram negative and Gram positive bacteria at
levels comparable to those reported previously in this context.
PCR amplification of bacterial DNA extracted from these samples
was found to be prevented.
Further evidence of the contribution of DNA from non-viable
sources to the culture-independent analysis of ascites comes from
comparison of the data presented here with that from an earlier
study [13] where a comparable sample set was analysed but
without PMA pre-treatment. The mean bacterial load reported in
this previous study was found to be significantly higher than those
reported here, suggesting DNA other than that present in viable
bacteria had made a substantial contribution to analysis. This
finding also provides a potential explanation for the previous
report of only partial correlation between the presence of bacterial
DNA in ascites and prognosis [29]. Whilst no approach can
completely exclude nucleic acids from non-viable bacteria to PCR-
based analysis, the approach applied here substantially improves
it.
As hypothesised, considerable diversity was observed by 16S
rRNA gene 454 pyrosequencing, despite the reduction in
amplifiable DNA that resulted from PMA treatment. More than
230 separate bacterial species detected in the sample set. Whilst
the bacterial loads determined by Q-PCR were relatively low, the
presence of viable bacteria within ascites, in the absence of clinical
SBP, suggests that the presence of bacteria is necessary but not
sufficient for this condition to develop. Therefore, all of the factors
required for the onset of SBP remain to be identified.
The presence of such a diverse array of bacterial species raises
the question of their origin. The principle source is believed to be
the gut, via translocation from the gastrointestinal lumen to the
mesenteric lymph nodes, and the subsequent systemic circulation
and seeding into ascites [29]. However, in addition, it may be
Table 2. Similarity of Percentages (SIMPER) analysis of bacterial community similarity (Bray-Curtis index) between patients.
Species Occupancy % Mean Abund. Mean Cont. % Cont. Cum. %
Acidovorax facilis 19 15.53 5.79 42.50 42.50
Stenotrophomonas maltophilia 16 6.64 2.19 16.09 58.60
Propionibacterium acnes 20 4.29 1.46 10.75 69.35
Streptococcus pneumoniae 10 4.93 0.84 6.19 75.54
Ralstonia pickettii 15 2.57 0.59 4.35 79.90
Given is occupancy, or number of patients a given species was detected in. Mean % abundance of species across the samples it was observed to occupy. Mean
contribution represents the average contribution of a given species to the average similarity between samples (overall mean= 13.6%). Percentage contribution is the
mean contribution divided by mean similarity across samples. The list of species is not exhaustive so cumulative % value does not sum to 100%. An arbitrary threshold
of a mean contribution of 0.5 was used as a cut-off.
doi:10.1371/journal.pone.0074884.t002
Table 3. Summary statistics for Mantel and partial Mantel
tests between community similarity and clinical factors.
Test
Similarity
(A)
Parameter
(B)
Control for
(C) r P
Mantel Sørensen Ascitic PMN 0.086 0.207
SBP 20.096 0.078
Child-Pugh
class
20.189 0.003*
Mantel Bray-Curtis Ascitic PMN 20.230 ,0.0001*
SBP 20.193 0.002*
Child-Pugh
class
20.155 0.011*
partial
Mantel
Bray-Curtis Ascitic PMN Child-Pugh
class
20.253 ,0.0001*
Child-Pugh
class
Ascitic PMN 20.190 0.003*
The Mantel statistic r(AB) estimates the correlations between two proximity
matrices, A and B. Whereas, the partial mantel statistic r(AB.C) estimates the
correlation between A and B whilst controlling for the effects of C. Given are
bacterial community similarity (Sørensen and Bray-Curtis indices of similarity)
and also differences in clinical factors. Also given is P to ascertain whether the
Mantel regression coefficients were significantly different from zero following
9,999 permutations. Asterisks denote those relationships that were significant
at the P,0.05 level.
doi:10.1371/journal.pone.0074884.t003
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possible for bacteria to translocate from other areas of the body
where bacterial populations overlay endothelia that may have
become porous to bacterial movement or be introduced via
indwelling devices. To some extent, the relative contribution of
these different potential routes can be inferred from the types of
bacterial species detected. Overall, 97% of the species identified
here were from within one of the four key phyla that comprise the
human microbiota; Proteobacteria, Firmicutes, Actinobacteria,
and Bacteroidetes. However, amongst these, Proteobacteria were
dominant, representing more than 60% of sequences detected.
The gut microbiota in healthy individuals is dominated by
Bacteroidetes and Firmicutes [30]. However, in patients with liver
cirrhosis, there is a decrease in the relative abundance of
Bacteroidetes and an increase in the relative abundance of
Proteobacteria and Fusobacteria [12,31]. Therefore, to some
extent, such a shift in gut microbiota composition could account
for the phylum level distribution of the bacterial species reported
here.
Examined in more detail, the increase in the relative abundance
of Proteobacteria in the intestinal microbiota of cirrhotic patients
is primarily the result of increases in Enterobacteriaceae and
Pasteurellaceae. In addition, there are increases in Streptococca-
ceae and Veillonellaceae [12], with Streptococcaceae in particular
shown to have a positive correlation trend with cirrhosis severity
[12]. Species belonging to Streptococcaceae were particularly
widely detected in the samples analysed here, in addition to other
species common within the intestinal microbiota, such as members
of the genera Bacteroides, Bifidobacterium, Clostridium, Eubacterium,
Fusobacterium, and Ruminococcus, supporting such a gut translocation
model.
However, in addition to gut-associated microbes, many other
species were detected that are far less likely to be present as the
result of translocation from the intestine, even where it is occupied
by a modified microbiota. For example, members of a number of
aerobic genera more commonly associated with opportunistic
infections, including Acinetobacter, Pseudomonas, Ralstonia, Stenotropho-
monas, and Staphylococcus, were detected. In other cases, members of
genera recognised as commonly colonising the skin, such as
members of the genus Propionibacterium, were present. Therefore,
whilst translocation of bacteria from the gut may be an important
route by which bacteria can enter ascites, the data presented here
suggest that it is not the only one.
A low level of microbiota similarity was observed between
patients. Similarity was also found to be low when the relative
abundance of these species was taken into account. This finding
suggests an element of stochasticity in the bacterial species present
in ascitic fluid. If so, this has by extension important implications
for treatment in that one antibiotic regime is unlikely to ‘‘cover’’
adequately such a diverse range of species. In the most part, these
species were classed as opportunist pathogens, and as such, these
would not be uncommon in a nosocomial environment.
Despite the divergence in bacterial species present in different
patients, microbiota membership and structure correlated closely
with differences in ascitic PMN and Child-Pugh class. Microbiota
similarity between patients, as measured by the Sorensen index
(species presence/absence) also correlated with these two clinical
factors (Table 3). No other clinical factors significantly correlated
with either measure of microbiota similarity. Partial Mantel tests
revealed that both differences in ascitic PMN and Child-Pugh class
both significantly correlated with microbiota similarity (when
species relative abundance was taken into account) even when
each factor was tested whilst controlling for the effects of the other.
This finding suggests that there may be a relationship between the
composition of the bacterial component of ascites and a patients
long-term prognosis, either through the existence of factors that
promote the translocation of these species to the peritoneal cavity,
or by predisposing patients to SBP or disease progression. As such,
this finding clearly warrants further investigation.
In detecting bacterial signal in the majority of ascitic fluid
analysed, the present study is in contrast with a number of
previous studies that have reported lower levels of sample positivity
for bacterial DNA. Negative controls were included in each step of
the analytical process, including PMA treatment, DNA extraction,
and PCR amplification, with no signal detected, supporting these
findings not being artefactual. Moreover, the dissimilarity of
species detected as present in the patients studied was not
consistent with any systematic contamination. Patient selection
may be one reason why the levels of sample positivity for bacterial
DNA detected here differs from some other studies. Some studies
have excluded patients with ascitic PMN counts .250/ml [10,11],
whereas here, no attempt was made to stratify patients, with those
included representing a cross-section of the patient population. In
many cases, these patients had indications of frank infection. In
addition, with the increasing sophistication of the molecular
detection systems, it is likely that detection thresholds of the Q-
PCR approach used here is lower than that previously achievable.
Where no bacterial signal was obtained from samples analysed in
the current study, a number of factors could contribute to the
failure of PCR amplification. For example, of the four patients
who provided PCR-negative samples three had non-alcoholic liver
disease. Here, the relative absence of intestinal permeability and
bacterial translocation [32] may have resulted in lower levels of
bacteria in ascites. The fourth PCR-negative patient was receiving
broad spectrum antibiotics at the time of sampling, again,
potentially reducing viable bacterial signal.
The study had a number of limitations that should be
considered. Analysis was performed on samples from a relatively
small group of subjects (n = 25), and application of the method-
ology described here to a larger patient populations would be likely
to further define the relationships between microbiological and
clinical measures reported. The majority of subjects were receiving
some form of antibiotic therapy at the time of sampling, a factor
that is likely to have influenced both the viable bacterial
composition of the ascites analysed, and the likelihood of samples
being culture-negative. Here, the subjects’ antibiotic treatment
profile reflects the fact that they were a cross-section of the patient
population. Analysis of samples obtained prior to, as well as during
antibiotic therapy would help to define the impact of such therapy
on the viable bacterial community in ascites. Such longitudinal
analysis would also provide greater insight into the relationship
between bacteriological factors and clinical progression. Finally,
whilst the identities of bacteria detected suggested potential routes
of entry into the peritoneal cavity, parallel analysis of stool
samples, samples from skin surrounding the drain site, and from
other areas from which bacteria might be derived, would provide
further clarification.
Taken together, the data presented here suggest that ascitic fluid
may be exposed to bacterial species from a range of sources, and
that access to the peritoneal cavity is non-limited to translocation
of bacteria from the gut. Further, they indicate that, whilst the
presence of bacteria in ascites is not sufficient for the occurrence of
SBP, a relationship exists between the composition of the bacterial
species content of ascites and clinical measures of disease.
Investigations of the changes that occur in these bacterial
communities during the development of SBP are now clearly
warranted.
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Supporting Information
Figure S1 Validation of PMA treatment in ascites fluid.
Lane 1– no template negative control. Lanes 2, 4, and 6–
amplification reactions using DNA extracted from heat-killed A.
baumanii, S. aureus, and E. coli, respectively, as template. Lanes 3, 5,
and 7 - amplification reactions using DNA extracted from PMA
treated heat-killed A. baumanii, S. aureus, and E. coli, respectively.
(DOCX)
Figure S2 Cluster diagrams of bacterial community
composition in the 21 patients. Patient species profiles were
compared using the (A) Sørensen and (B) Bray-Curtis quantitative
indices of similarity and average linkage clustering.
(TIF)
Table S1 Bacterial species sampled across the 21 cross-
sectional samples. Occupancy denotes the number of samples
a given species was detected in. Respiration - Ae, denotes aerobe;
An, Anerobe1.
(DOCX)
Methods S1 Full details of methods used in nucleic acid
extraction, quantitative PCR, 16S rRNA gene pyrose-
quencing, and statistical analysis.
(DOC)
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